Insider Stock Trading History of Przybyl Arthur


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Przybyl Arthur since year 2005. The trader's CIK number is 1268135. At the time of this reporting, Przybyl Arthur is the President and CEO of Biosante Pharmaceuticals Inc . (stock ticker symbol bpa). See this page for all insider trading activities at Biosante Pharmaceuticals Inc .

Note that in the past PRZYBYL ARTHUR also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Przybyl Arthur since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2016-08-22 ANIP Biosante Pharmaceuticals Inc Option Ex 53,178 15.24 810,432
2016-08-22 ANIP Biosante Pharmaceuticals Inc Sale 37,455 66.97 2,508,361
2016-01-08 ANIP Biosante Pharmaceuticals Inc Option Ex 16,446 6.36 104,596
2015-11-12 ANIP Biosante Pharmaceuticals Inc Buy 2,500 40.95 102,375
2015-08-10 ANIP Biosante Pharmaceuticals Inc Option Ex 10,000 6.36 63,600
2015-05-07 ANIP Biosante Pharmaceuticals Inc Option Ex 5,000 6.36 31,800
2015-03-12 ANIP Biosante Pharmaceuticals Inc Sale 75,000 63.00 4,725,000
2014-09-09 ANIP Biosante Pharmaceuticals Inc Buy 1,000 26.50 26,500
2008-12-31 AKRX Akorn Inc Option Ex 1,221,258 2.21 2,696,537
2008-12-18 AKRX Akorn Inc Option Ex 54,688 2.23 121,680
2008-12-19 AKRX Akorn Inc Option Ex 62,144 2.23 138,394
2008-12-15 AKRX Akorn Inc Option Ex 69,193 2.35 162,603
2008-12-16 AKRX Akorn Inc Option Ex 42,852 2.30 98,645
2008-12-17 AKRX Akorn Inc Option Ex 32,789 2.24 73,480
2008-06-20 AKRX Akorn Inc Sale 251,850 3.41 859,815
2008-06-23 AKRX Akorn Inc Sale 21,152 3.33 70,351
2007-12-18 AKRX Akorn Inc Option Ex 75,000 .85 63,750
2006-12-12 AKN Akorn Inc Option Ex 300,000 1.10 330,000
2006-12-12 AKN Akorn Inc Sale 300,000 .00 0

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Przybyl Arthur (President and CEO of Biosante Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.